ConductScience.org, home

Paper31862005

Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.

Fletcher EJR and 2 others. BMC Neurosci, 2019. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease. Papers, record 31862005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31862005

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
PubMed
Journal
BMC Neurosci
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.34
iCite
Revised in PubMed
2020-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fletcher EJREdward J R
2Moon LDFLawrence D F
3Duty SSusanhttps://orcid.org/0000-0003-3408-5973

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chondroitin ABC LyaseMajor topic
Corpus StriatumMajor topic
Dopaminergic NeuronsMajor topic
Neuroprotective AgentsMajor topic
Parkinsonian DisordersMajor topic
Substantia NigraMajor topic
Animals
Antiparkinson Agents
Cell Death
Male
Mice, Inbred C57BL
Motor Activity
Oxidopamine

Source PubMed

Download CSV of topics

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122404342Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease.Br J Pharmacol2012https://conductscience.org/library/papers/22404342PubMed
218005340Chondroitinase ABC has a long-lasting effect on chondroitin sulphate glycosaminoglycan content in the injured rat brain.J Neurochem2008https://conductscience.org/library/papers/18005340PubMed
321697383Chondroitinase combined with rehabilitation promotes recovery of forelimb function in rats with chronic spinal cord injury.J Neurosci2011https://conductscience.org/library/papers/21697383PubMed
417394547Mammalian-produced chondroitinase AC mitigates axon inhibition by chondroitin sulfate proteoglycans.J Neurochem2007https://conductscience.org/library/papers/17394547PubMed
529912283Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury.Brain2018https://conductscience.org/library/papers/29912283PubMed
615721753Chondroitin sulfate proteoglycans in neural development and regeneration.Curr Opin Neurobiol2005https://conductscience.org/library/papers/15721753PubMed
710699444CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury.Neuropharmacology2000https://conductscience.org/library/papers/10699444PubMed
830323743Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson's Disease.Front Cell Neurosci2018https://conductscience.org/library/papers/30323743PubMed
922146593Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites.Behav Brain Res2012https://conductscience.org/library/papers/22146593PubMed
1028713483The Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats.Oxid Med Cell Longev2017https://conductscience.org/library/papers/28713483PubMed
1119668200Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation.Nat Neurosci2009https://conductscience.org/library/papers/19668200PubMed
1229909247Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson's disease.Pharmacol Rep2018https://conductscience.org/library/papers/29909247PubMed
1326044197Chondroitinase gene therapy improves upper limb function following cervical contusion injury.Exp Neurol2015https://conductscience.org/library/papers/26044197PubMed
1457185106-Hydroxy-dopamine induced degeneration of central monoamine neurons.Eur J Pharmacol1968https://conductscience.org/library/papers/5718510PubMed
1528756859Improvement of activity and stability of Chondroitinase ABC I by introducing an aromatic cluster at the surface of protein.Enzyme Microb Technol2017https://conductscience.org/library/papers/28756859PubMed
1619759203A clinico-pathological study of subtypes in Parkinson's disease.Brain2009https://conductscience.org/library/papers/19759203PubMed
1715385557
Structural and functional characterization of oversulfated chondroitin sulfate/dermatan sulfate hybrid chains from the notochord of hagfish. Neuritogenic and binding activities for growth factors and neurotrophic factors.
J Biol Chem2004https://conductscience.org/library/papers/15385557PubMed
188929429Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease.J Neurosci1996https://conductscience.org/library/papers/8929429PubMed
1924695702Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury.J Neurosci2014https://conductscience.org/library/papers/24695702PubMed
2028801819Treadmill Exercise Prevents Increase of Neuroinflammation Markers Involved in the Dopaminergic Damage of the 6-OHDA Parkinson's Disease Model.J Mol Neurosci2017https://conductscience.org/library/papers/28801819PubMed

See all 48 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42020548Extracellular matrix remodelling in neurological diseases.Nat Rev Neurol2026https://conductscience.org/library/papers/42020548PubMed
40623478Inhibition of PTPRS function does not affect the survival or regeneration of dopaminergic neurons but alters synaptic function in the nigrostriatal pathway.Neurobiol Dis2025https://conductscience.org/library/papers/40623478PubMed
39688547Neuronal plasticity and its role in Alzheimer's disease and Parkinson's disease.Neural Regen Res2026https://conductscience.org/library/papers/39688547PubMed
35890231A Single Domain Shark Antibody Targeting the Transferrin Receptor 1 Delivers a TrkB Agonist Antibody to the Brain and Provides Full Neuroprotection in a Mouse Model of Parkinson's Disease.Pharmaceutics2022https://conductscience.org/library/papers/35890231PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31862005

GET https://conductscience.org/api/papers/v1/31862005/references?page=2